Vander Vort John

CIK 00013792188 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001379218

Recent Transactions

50 trades

Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−7,500→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Common Stock
2019-07-18−43,000→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−7,500→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−7,500→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−10,000→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−13,237→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−7,500→ 0 total
Disposition to Issuer
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-07-18−10,000→ 0 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2019-06-06+7,500→ 7,500 total
Award
ARATANA THERAPEUTICS, INC.
Common Stock
2019-06-06+4,500→ 43,000 total
Award
ARATANA THERAPEUTICS, INC.
Common Stock
2018-07-27+4,500→ 38,500 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2018-07-27+7,500→ 7,500 total
Award
ARATANA THERAPEUTICS, INC.
Common Stock
2017-06-21+4,500→ 34,000 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2017-06-21+7,500→ 7,500 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2016-06-24+7,500→ 7,500 total
Award
ARATANA THERAPEUTICS, INC.
Common Stock
2016-06-24+4,500→ 29,500 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2015-06-18+10,000→ 10,000 total
Sale
ARATANA THERAPEUTICS, INC.
Common Stock
2015-03-06$20.01/sh−6,137→ 25,000 total
Conversion
Histogen Inc.
Common Stock
2013-07-30+1,010,099→ 1,010,099 total
Other
Histogen Inc.
Common Stock
2013-07-30$11.00/sh+16,716→ 1,026,815 total
Purchase
Histogen Inc.
Common Stock
2013-07-30$11.00/sh+165,265→ 1,192,080 total
Conversion
Histogen Inc.
Warrant to Purchase Common Stock (Right to Buy)
2013-07-30+32,220→ 32,220 total
Conversion
Histogen Inc.
Series B Convertible Preferred Stock
2013-07-30−8,333,334→ 0 total
Conversion
Histogen Inc.
Warrant to Purchase Series B Preferred Stock (Right to Buy)
2013-07-30−265,837→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Series A Preferred Stock
2013-07-02−4,000,000→ 0 total
Purchase
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02$6.00/sh+500,000→ 4,351,050 total
Conversion
ARATANA THERAPEUTICS, INC.
Series C Preferred Stock
2013-07-02−375,000→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+2,406,739→ 2,823,173 total
Conversion
ARATANA THERAPEUTICS, INC.
Series B Preferred Stock
2013-07-02−1,333,333→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+802,246→ 3,625,419 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+225,631→ 3,851,050 total
Award
ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2013-06-26+13,237→ 13,237 total
Conversion
Epizyme, Inc.
Common Stock
2013-06-05+2,309,998→ 2,488,329 total
Conversion
Epizyme, Inc.
Common Stock
2013-06-05+392,156→ 2,880,485 total
Conversion
Epizyme, Inc.
Series A Preferred Stock
2013-06-05−6,930,000→ 0 total
Conversion
Epizyme, Inc.
Series B Preferred Stock
2013-06-05−1,176,472→ 0 total
Purchase
Radius Health, Inc.
Series B Convertible Preferred Stock
2013-04-23$61.42/sh+71,638→ 71,638 total
Purchase
Radius Health, Inc.
Common Stock Warrant
2013-04-23$6.14/sh+179,095→ 179,095 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2013-03-11$27.86/sh−500,000→ 2,790,479 total
Conversion
Pacira BioSciences, Inc.$PCRX
Convertible Promissory Note
2012-02-08−712,567→ 0 total
Purchase
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08$7.00/sh+267,857→ 2,561,084 total
Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08+1,487,680→ 1,580,660 total
Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08+712,567→ 2,293,227 total
Purchase
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08$7.00/sh+267,857→ 2,828,941 total
Conversion
Pacira BioSciences, Inc.$PCRX
Series A Convertible Preferred Stock
2012-02-08−1,487,680→ 0 total
Conversion
Verastem, Inc.$VSTM
Series B Preferred Stock
2012-02-01−2,500,000→ 0 total
Conversion
Verastem, Inc.$VSTM
Common Stock
2012-02-01+1,933,333→ 1,933,333 total
Purchase
Verastem, Inc.$VSTM
Common Stoc
2012-02-01$10.00/sh+100,000→ 2,033,333 total
Conversion
Verastem, Inc.$VSTM
Series A Preferred Stock
2012-02-01−4,000,000→ 0 total
Conversion
Verastem, Inc.$VSTM
Seriec C Preferred Stock
2012-02-01−266,666→ 0 total

Companies

Recent Filings

Address

C/O MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR

BOSTON, MA, 02116

View on SEC.gov